MYCELX Technologies (LON:MYX – Get Rating)‘s stock had its “speculative buy” rating reaffirmed by analysts at Canaccord Genuity Group in a research note issued on Friday, Marketbeat reports. They currently have a GBX 95 ($1.19) price objective on the stock. Canaccord Genuity Group’s price objective would indicate a potential upside of 187.88% from the company’s current price.
MYCELX Technologies Stock Performance
Shares of MYX stock opened at GBX 33 ($0.41) on Friday. The firm has a market capitalization of £7.58 million, a P/E ratio of -183.33 and a beta of 0.89. MYCELX Technologies has a twelve month low of GBX 19 ($0.24) and a twelve month high of GBX 52.50 ($0.66). The company has a quick ratio of 2.97, a current ratio of 6.50 and a debt-to-equity ratio of 11.51. The stock’s fifty day simple moving average is GBX 33.62 and its 200 day simple moving average is GBX 30.31.
MYCELX Technologies Company Profile
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Receive News & Ratings for MYCELX Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MYCELX Technologies and related companies with MarketBeat.com's FREE daily email newsletter.